相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A dysregulated interleukin-18-interferon-γ-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis
Tanja Hinze et al.
RHEUMATOLOGY (2021)
Canakinumab for Pulmonary Artery Hypertension and Macrophage Activation Syndrome Associated with Uncontrolled Systemic Juvenile Idiopathic Arthritis
Luciana Brandao Paim et al.
INDIAN JOURNAL OF PEDIATRICS (2021)
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Esraa M. Eloseily et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management
Lauren A. Henderson et al.
PEDIATRIC DRUGS (2020)
The genetics of macrophage activation syndrome
Grant S. Schulert et al.
GENES AND IMMUNITY (2020)
Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
Riccardo Papa et al.
PEDIATRIC RHEUMATOLOGY (2020)
Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience
Kenan Barut et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Emergent high fatality lung disease in systemic juvenile arthritis
Vivian E. Saper et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis
Benedetta Saccomanno et al.
JOURNAL OF RHEUMATOLOGY (2019)
Pediatric rheumatology infusion center: report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year
Surabhi S. Vinod et al.
PEDIATRIC RHEUMATOLOGY (2018)
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis
Grant S. Schulert et al.
ARTHRITIS CARE & RESEARCH (2018)
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Angelo Ravelli et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Whole-Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
Kenneth M. Kaufman et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2013)
Treatment of Juvenile Idiopathic Arthritis in the Biologic Age
Matthew L. Stoll et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2013)
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Abhijit Chakraborty et al.
CLINICAL PHARMACOKINETICS (2012)
Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment
A. Ravelli et al.
GENES AND IMMUNITY (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
Jasmin B. Kuemmerle-Deschner et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
Jessica L. Record et al.
JOURNAL OF RHEUMATOLOGY (2011)
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
Paivi M. Miettunen et al.
RHEUMATOLOGY (2011)
American College of Rheumatology Provisional Criteria for Defining Clinical Inactive Disease in Select Categories of Juvenile Idiopathic Arthritis
Carol A. Wallace et al.
ARTHRITIS CARE & RESEARCH (2011)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
V Pascual et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
分享论文
